Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;34(4):e14975.
doi: 10.1111/dth.14975. Epub 2021 May 26.

Immunotherapy in transplanted patients: A special population that can no longer be ignored

Marco Rubatto  1 , Martina Merli  1 , Andrea Agostini  1 , Gianluca Avallone  1 , Luca Mastorino  1 , Paolo Fava  1 , Luigi Biancone  2 , Maura Rossetti  2 , Maria Teresa Fierro  1 , Simone Ribero  1 , Pietro Quaglino  1
Affiliations

Immunotherapy in transplanted patients: A special population that can no longer be ignored

Marco Rubatto et al. Dermatol Ther. 2021 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
A, Cutaneous squamous cell carcinoma (cSCC) on the left arm before starting the therapy with cemiplimab. B, cSCC on the left arm after the third infusion of cemiplimab
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Migden MR, Rischin D, Schmults CD, et al. PD‐1 blockade with cemiplimab in advanced cutaneous squamous‐cell carcinoma. N Engl J Med. 2018;379(4):341‐351. 10.1056/NEJMoa1805131. - DOI - PubMed
    1. Migden MR, Khushalani NI, Chang ALS, et al. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open‐label, phase 2, single‐arm trial. Lancet Oncol. 2020;21(2):294‐305. 10.1016/S1470-2045(19)30728-4. - DOI - PMC - PubMed
    1. Hober C, Fredeau L, Ledard AP, et al. 1086P Cemiplimab for advanced cutaneous squamous cell carcinoma: real life experience. Ann Oncol. 2020;31:S737. 10.1016/j.annonc.2020.08.1210. - DOI
    1. Migden MR, Chandra S, Rabinowits G, et al. CASE (CemiplimAb‐rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma. Future Oncol. 2020;16(4):11‐19. 10.2217/fon-2019-0762. - DOI - PubMed
    1. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348:1681‐1691. - PubMed

Substances